Chad Young
Director/Board Member at Clene Nanomedicine, Inc.
Profile
Chad Young is currently a Director at Clene Nanomedicine, Inc. He was previously a Director-Global Talent Development at Textron, Inc. and an Executive Vice President at GeNOsys, Inc. Mr. Young has a graduate degree from Brigham Young University and a graduate degree from Youngstown State University.
Chad Young active positions
Companies | Position | Start |
---|---|---|
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
Former positions of Chad Young
Companies | Position | End |
---|---|---|
TEXTRON INC. | Corporate Officer/Principal | - |
GeNOsys, Inc.
GeNOsys, Inc. Pharmaceuticals: MajorHealth Technology GeNOsys, Inc. is a medical research and development company, which specializes in pharmaceutical, biotechnical and medical gas generating systems. The company was founded by John W. Randy Miller on June 30, 2005 and is headquartered in Orem, UT. | Corporate Officer/Principal | - |
Training of Chad Young
Youngstown State University | Graduate Degree |
Brigham Young University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TEXTRON INC. | Electronic Technology |
Private companies | 2 |
---|---|
GeNOsys, Inc.
GeNOsys, Inc. Pharmaceuticals: MajorHealth Technology GeNOsys, Inc. is a medical research and development company, which specializes in pharmaceutical, biotechnical and medical gas generating systems. The company was founded by John W. Randy Miller on June 30, 2005 and is headquartered in Orem, UT. | Health Technology |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
- Stock Market
- Insiders
- Chad Young